Novavax, Inc. share price logo

Novavax, Inc. Share Price

NASDAQ: NVAX

Small Cap

$7.88

-0.10

(-1.19%)

Live

as on

Novavax, Inc. Stock Performance

as on September 15, 2025 at 11:38 pm IST

  • Day's High

    $7.88
    $8.15

    3.43%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $5.01
    $15.22
    downward going graph

    36.42%

    Downside

    93.15%

    Upside

    downward going graph

Novavax, Inc. share price movements today

Previous Close
$7.98
Open
$8.00
Volume
2.8M
Day's Low - High
$7.88 - $8.15
52 Week Low - High
$5.01 - $15.22

Novavax, Inc. Historical Returns

1 Month Return
-16.7 %
3 Month Return
+ 14.99 %
1 Year Return
-41.37 %
3 Year Return
-75.48 %
5 Year Return
-92.77 %

Novavax, Inc. Stock Fundamentals & Key Indicators

Check Novavax, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$1.3B

EPS (TTM)

2.6155

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

-0.38%

PE Ratio (TTM)

3.59

Industry PE ratio

-3.8535542168674697

P/B Ratio

3.5946

PEG Ratio

0

EBITDA

407.5M

Revenue (TTM)

1.1B

Profit Margin

39.20%

Return On Equity TTM

-898.20%

Novavax, Inc. Stock Valuation

Track how Novavax, Inc. P/E has moved over time to understand its valuation trends.

Novavax, Inc. in the last 5 years

  • Overview

  • Trends

Lowest (2.91x)

June 30, 2025

Industry (-3.85x)

September 15, 2025

Today (3.59x)

September 15, 2025

Highest (3.13x)

March 31, 2025

LowHigh

Today’s Price to Earnings Ratio: 3.59x

Novavax, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Novavax, Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$1.3B-92.77%3.5939.20%
BUY$61.1B256.98%-505.15-12.96%
NA$38.7BNANA-3.89%
BUY$101.1B47.85%28.0731.86%
BUY$59.4B-3.43%14.1131.37%

Stock Returns calculator for Novavax, Inc. Stock including INR - Dollar returns

The Novavax, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Novavax, Inc. investment value today

Current value as on today

₹62,884

Returns

₹37,116

(-37.12%)

Returns from Novavax, Inc. Stock

₹42,101 (-42.1%)

Dollar Returns*

₹4,985 (+4.99%)

Analyst Recommendation on Novavax, Inc. Stock

Based on 12 analysts

BUY

66.67%

Buy

16.67%

Hold

16.67%

Sell

Based on 12 analysts, 66.67% of analysts recommend a 'BUY' rating for Novavax, Inc.. Average target price of $12.5

Novavax, Inc. Share Price Target

Get share price movements and forecasts by analysts on Novavax, Inc..

What analysts predicted

36.96%UPSIDE

Target Price

$12.5

Current Price

$7.88

Analyzed by

12 Analysts

Target

$12.50

Novavax, Inc. target price $12.5, a slight upside of 36.96% compared to current price of $7.88. According to 12 analysts rating.

Novavax, Inc. Stock's Interest Amongst Investors

Investment in Novavax, Inc. Shares on INDmoney has grown by 7.14% over the past 30 days, indicating increased transactional activity.

Time period: to

Change:7.14% versus previous 30 day period

Search interest for Novavax, Inc. Stock has decreased by -2% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-2% versus previous 30 day period

Novavax, Inc. Quarterly Profit & Loss

All numbers in Millions USD

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Total Revenue
80
424
22
291
93
415
84
88
666
239
Gross Profit
46
368
-76
142
45
379
23
51
652
225
Operating Income
-312
55
-125
-183
-138
160
-134
-131
515
105
EBITDA
-279
71
-117
-161
-129
179
-105
-53
533
120
Interest Expense
4
3
2
4
4
4
4
7
5
5
Depreciation
9
10
11
10
12
11
12
12
8
7
Income Before Tax
-292
57
-131
-176
-145
164
-122
-73
519
107
Income Tax Expense
1
0
0
1
2
2
-1
7
1
0
Net Income
-293
58
-130
-178
-147
162
-121
-81
518
106
Net Profit Margin
-363.07%
13.67%
-592.71%
-61.23%
-157.21%
39.08%
-143.53%
-91.76%
77.80%
44.52%

Novavax, Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2015
Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
36
15
31
34
18
475
1,146
1,598
556
682
Gross Profit
-126
-222
31
34
-95
475
1,146
696
212
479
Operating Income
-157
-269
-171
-173
-120
-416
-1,686
-644
-566
-248
EBITDA
-151
-260
-161
-165
-114
-411
-1,673
-604
-487
-108
Interest Expense
0
12
14
12
12
15
21
19
14
20
Depreciation
-
-
9
8
5
4
12
29
37
48
Income Before Tax
-156
-279
-183
-184
-132
-418
-1,714
-653
-543
-176
Income Tax Expense
-6
2
2
1
-2
9
29
4
2
10
Net Income
-156
-279
-183
-184
-130
-427
-1,743
-657
-545
-187
Net Profit Margin
-432.93%
-1823.53%
-589.46%
-538.81%
-697.15%
-89.89%
-152.12%
-41.15%
-97.97%
-27.49%

Novavax, Inc. Quarterly Cash Flow

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Net Income
58
-130
-178
-147
162
-121
-81
518
106
Operating Cash Flow
-171
-39
-176
-83
314
-144
-173
-185
-127
Investing Cash Flow
-7
-18
-9
-7
-372
31
144
-73
111
Financing Cash Flow
61
197
100
5
258
0
-3
-7
-1
Change in Cash
-119
148
-82
-87
199
-102
-43
-266
-9

Novavax, Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-279
-183
-184
-132
-418
-1,743
-657
-545
-187
Operating Cash Flow
-255
-138
-184
-136
-42
322
-415
-713
-87
Investing Cash Flow
28
35
28
38
-377
100
-92
-58
-204
Financing Cash Flow
279
64
102
98
984
461
324
4
260
Change in Cash
51
-38
-53
0
566
879
-179
-765
-38

Global Institutional Holdings in Novavax, Inc.

Funds
Holdings
Vanguard Group Inc
9.65%
BlackRock Inc
7.98%
Shah Capital Management
7.09%
State Street Corp
4.33%
Sanofi
4.24%

Insights on Novavax, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 75.6% return, outperforming this stock by 117.0%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 123.5% return, outperforming this stock by 199.0%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 666.65M → 239.24M (in $), with an average decrease of 64.1% per quarter

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, NVAX stock has moved down by -16.7%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 518.64M → 106.50M (in $), with an average decrease of 79.5% per quarter

About Novavax, Inc.

"Novavax, Inc. is a biotechnology company focused on delivering novel products that effectively use innovative technology to solve known and emerging disease threats. The biotechnology giant is dedicated to creating cost-effective and democratized vaccine solutions for infectious diseases, such as seasonal flu, Ebola, COVID-19, and more. Founded in 1987, Novavax, Inc. is headquartered in Gaithersburg, Maryland. It specializes in developing recombinant vaccines, and its lineup includes NVX-CoV2373, NanFlu, and ResVax, helpful in treating or preventing coronavirus, seasonal quadrivalent influenza, and a respiratory syncytial virus, respectively. Novavax, Inc. is also testing Matrix-M and its EBOV vaccine candidate in the Phase I clinical trial. It is also developing additional pre-clinical stage vaccine programs for occurrences such as MERS. It presently has over 750 employees, and its Nuvaxovid, a COVID-19 solution, is the fifth approved vaccine in the European Union. Further, Novavax has also filed the complete CMC data package with the FDA. It combines Novavax’s manufacturing prowess with Serum Institute of India Pvt. Ltd. (SII)’s experience for improved vaccine manufacturing. In addition, it also purchased Praha Vaccines and its vaccine factory in the Czech Republic, having a capacity of 1 billion doses per year. Currently Novavax, Inc. has a market cap of $1.30 Billion. It has a P.E ratio of 3.59. The shares of Novavax, Inc. are trading at {current share price in dollars (in INR)}."
OrganisationNovavax, Inc.
Headquarters700 Quince Orchard Road, Gaithersburg, MD, United States, 20878
IndustryHealth Technology
CEOMr. John Charles Jacobs M.B.A.
E-voting on sharesClick here to vote

Key Management of Novavax, Inc.

Name

Title

Mr. Troy Morgan Esq., J.D.

Senior VP, Deputy General Counsel & Chief Compliance Officer

Mr. Ian J. Watkins

Executive VP & Chief Human Resources Officer

Ms. Silvia Taylor M.B.A.

Executive VP and Chief Corporate Affairs & Advocacy Officer

Dr. Henrietta Ukwu FACP FRAPS, M.D.

Executive VP & Chief Regulatory Officer

Mr. John Charles Jacobs M.B.A.

President, CEO & Director

Mr. James Patrick Kelly C.F.A.

Executive VP, CFO & Treasurer

Mr. Mark J. Casey Esq.

Executive VP, Chief Legal Officer & Corporate Secretary

Ms. Elaine O'Hara

Executive VP & Chief Strategy Officer

Mr. Richard P. Crowley

Executive VP & COO

Ms. Erika S. Trahan

Associate Director of Investor & Public Relations

FAQs

What is Novavax, Inc. share price today?

Novavax, Inc. share price today is $7.88 as on . Novavax, Inc. share today touched a day high of $8.15 and a low of $7.88.

What is the 52 week high and 52 week low for Novavax, Inc. share?

Novavax, Inc. share touched a 52 week high of $15.22 on and a 52 week low of $5.01 on . Novavax, Inc. stock price today i.e. is trending at $7.88,which is 48.23% down from its 52 week high and 57.29% up from its 52 week low.

What is Novavax, Inc.'s market capitalisation today?

Novavax, Inc. market capitalisation is $0.00T as on .

How to invest in Novavax, Inc. Stock (NVAX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Novavax, Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Novavax, Inc. Shares that will get you 0.1904 shares as per Novavax, Inc. share price of $7.88 per share as on September 15, 2025 at 11:38 pm IST.

What is the minimum amount required to buy Novavax, Inc. Stock (NVAX) from India?

Indian investors can start investing in Novavax, Inc. (NVAX) shares with as little as ₹88.141 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.41 in Novavax, Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Novavax, Inc. share’s latest price of $7.88 as on September 15, 2025 at 11:38 pm IST, you will get 1.2690 shares of Novavax, Inc.. Learn more about fractional shares .

What are the returns that Novavax, Inc. has given to Indian investors in the last 5 years?

Novavax, Inc. stock has given -92.77% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?